{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:56:13Z","timestamp":1790398573314,"version":"4.1.0"},"reference-count":190,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T00:00:00Z","timestamp":1558742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"POC","award":["35\/ 01.09.2016"],"award-info":[{"award-number":["35\/ 01.09.2016"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mass spectrometry (MS) is an essential analytical technology on which the emerging omics domains; such as genomics; transcriptomics; proteomics and metabolomics; are based. This quantifiable technique allows for the identification of thousands of proteins from cell culture; bodily fluids or tissue using either global or targeted strategies; or detection of biologically active metabolites in ultra amounts. The routine performance of MS technology in the oncological field provides a better understanding of human diseases in terms of pathophysiology; prevention; diagnosis and treatment; as well as development of new biomarkers; drugs targets and therapies. In this review; we argue that the recent; successful advances in MS technologies towards cancer omics studies provides a strong rationale for its implementation in biomedicine as a whole.<\/jats:p>","DOI":"10.3390\/ijms20102576","type":"journal-article","created":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T23:07:27Z","timestamp":1558912047000},"page":"2576","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer \u201cOmics\u201d"],"prefix":"10.3390","volume":"20","author":[{"given":"Cristina Alexandra","family":"Ciocan-Cartita","sequence":"first","affiliation":[{"name":"MEDFUTURE -Research Center for Advanced Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 4-6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancu\u021ba","family":"Jurj","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy; 23 Marinescu Street, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-9961","authenticated-orcid":false,"given":"Mihail","family":"Buse","sequence":"additional","affiliation":[{"name":"MEDFUTURE -Research Center for Advanced Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 4-6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-8626","authenticated-orcid":false,"given":"Diana","family":"Gulei","sequence":"additional","affiliation":[{"name":"MEDFUTURE -Research Center for Advanced Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 4-6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Braicu","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy; 23 Marinescu Street, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3926-5423","authenticated-orcid":false,"given":"Lajos","family":"Raduly","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy; 23 Marinescu Street, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7450-9454","authenticated-orcid":false,"given":"Roxana","family":"Cojocneanu","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy; 23 Marinescu Street, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia Lorena","family":"Pruteanu","sequence":"additional","affiliation":[{"name":"MEDFUTURE -Research Center for Advanced Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 4-6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0345-0993","authenticated-orcid":false,"given":"Cristina Adela","family":"Iuga","sequence":"additional","affiliation":[{"name":"MEDFUTURE -Research Center for Advanced Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 4-6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania"},{"name":"Department of Pharmaceutical Analysis, Faculty of Pharmacy, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8865-2913","authenticated-orcid":false,"given":"Ovidiu","family":"Coza","sequence":"additional","affiliation":[{"name":"Department of Oncology, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania"},{"name":"Department of Radiotherapy with High Energies and Brachytherapy, Oncology Institute \u201cProf. Dr. Ion Chiricuta\u201d, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-1325","authenticated-orcid":false,"given":"Ioana","family":"Berindan-Neagoe","sequence":"additional","affiliation":[{"name":"MEDFUTURE -Research Center for Advanced Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 4-6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania"},{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy; 23 Marinescu Street, 400337 Cluj-Napoca, Romania"},{"name":"Department of Functional Genomics and Experimental Pathology, Ion Chiricu\u021b\u01ce Oncology Institute, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/526335a","article-title":"Precision medicine","volume":"526","author":"Bahcall","year":"2015","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1158\/1078-0432.CCR-13-2500","article-title":"Molecular pathways: Micrornas, cancer cells, and microenvironment","volume":"20","author":"Calin","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3322\/caac.21244","article-title":"Micrornaome genome: A treasure for cancer diagnosis and therapy","volume":"64","author":"Pasculli","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.15252\/emmm.201506055","article-title":"The dark matter of the cancer genome: Aberrations in regulatory elements, untranslated regions, splice sites, non-coding rna and synonymous mutations","volume":"8","author":"Diederichs","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jacob, R., Zander, S., and Gutschner, T. (2017). The dark side of the epitranscriptome: Chemical modifications in long non-coding rnas. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112387"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2174\/0929867311320290002","article-title":"Micrornas and cancer therapy-from bystanders to major players","volume":"20","author":"Braicu","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/35057267","article-title":"Our genome unveiled","volume":"409","author":"Baltimore","year":"2001","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.18632\/oncotarget.1292","article-title":"Ccat2, a novel long non-coding rna in breast cancer: Expression study and clinical correlations","volume":"4","author":"Redis","year":"2013","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.molcel.2016.01.015","article-title":"Allele-specific reprogramming of cancer metabolism by the long non-coding rna, ccat2","volume":"61","author":"Redis","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/acs.bioconjchem.8b00003","article-title":"Exosomes-small players, big sound","volume":"29","author":"Gulei","year":"2018","journal-title":"Bioconjug Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cdd.2014.130","article-title":"Exosomes as divine messengers: Are they the hermes of modern molecular oncology?","volume":"22","author":"Braicu","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1038\/onc.2014.456","article-title":"Junk DNA and the long non-coding rna twist in cancer genetics","volume":"34","author":"Ling","year":"2015","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00345-007-0206-3","article-title":"Mass spectrometry based proteomics in urine biomarker discovery","volume":"25","author":"Theodorescu","year":"2007","journal-title":"World J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Pistol, G.C., Braicu, C., Motiu, M., Gras, M.A., Marin, D.E., Stancu, M., Calin, L., Israel-Roming, F., Berindan-Neagoe, I., and Taranu, I. (2015). Zearalenone mycotoxin affects immune mediators, mapk signalling molecules, nuclear receptors and genome-wide gene expression in pig spleen. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127503"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2147\/DDDT.S142337","article-title":"The new era of nanotechnology, an alternative to change cancer treatment","volume":"11","author":"Jurj","year":"2017","journal-title":"Drug Des. Devel Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jgg.2011.02.003","article-title":"The impact of next-generation sequencing on genomics","volume":"38","author":"Zhang","year":"2011","journal-title":"J. Genet. Genom."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1576\/toag.13.3.189.27672","article-title":"Sac review \u2018omic\u2019technologies: Genomics, transcriptomics, proteomics and metabolomics","volume":"13","author":"Richard","year":"2011","journal-title":"Obstet. Gynaecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.breast.2017.11.006","article-title":"Genetic alterations in sporadic triple negative breast cancer","volume":"38","author":"Pop","year":"2017","journal-title":"Breast"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhang, Z.H., Jhaveri, D.J., Marshall, V.M., Bauer, D.C., Edson, J., Narayanan, R.K., Robinson, G.J., Lundberg, A.E., Bartlett, P.F., and Wray, N.R. (2014). A comparative study of techniques for differential expression analysis on rna-seq data. PLoS ONE, 9.","DOI":"10.1101\/005611"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hrdlickova, R., Toloue, M., and Tian, B. (2017). Rna-seq methods for transcriptome analysis. Wiley Interdiscip. Rev. RNA, 8.","DOI":"10.1002\/wrna.1364"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.RES.0000071748.48338.25","article-title":"Organelle proteomics: Implications for subcellular fractionation in proteomics","volume":"92","author":"Huber","year":"2003","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.blre.2007.07.002","article-title":"How will haematologists use proteomics?","volume":"21","author":"Unwin","year":"2007","journal-title":"Blood Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jprot.2011.09.014","article-title":"Proteomic databases and tools to decipher post-translational modifications","volume":"75","author":"Kamath","year":"2011","journal-title":"J. Proteom."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0076-6879(09)63019-6","article-title":"Isolation of subcellular organelles and structures","volume":"463","author":"Michelsen","year":"2009","journal-title":"Methods Enzym."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/nprot.2006.273","article-title":"Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics","volume":"1","author":"Cox","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_26","first-page":"226","article-title":"Proteomics: New insights into rheumatic diseases","volume":"3","author":"Camafeita","year":"2009","journal-title":"Proteomics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/pmic.200402106","article-title":"Proteomic characterization of human normal articular chondrocytes: A novel tool for the study of osteoarthritis and other rheumatic diseases","volume":"5","author":"Blanco","year":"2005","journal-title":"Proteomics"},{"key":"ref_28","first-page":"904","article-title":"Genomics and proteomics: A new approach for assessing thrombotic risk in autoimmune diseases","volume":"17","author":"Barbarroja","year":"2008","journal-title":"Lupus"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/prca.200800178","article-title":"Proteomics in obesity research","volume":"3","author":"Gomis","year":"2009","journal-title":"Proteom. Clin. Appl."},{"key":"ref_30","first-page":"17041","article-title":"The use of proteomics in urological research","volume":"102","author":"Rehman","year":"2005","journal-title":"Mol. Biol. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1021\/cr3003533","article-title":"Protein analysis by shotgun\/bottom-up proteomics","volume":"113","author":"Zhang","year":"2013","journal-title":"Chem. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbrc.2014.02.041","article-title":"Top down proteomics: Facts and perspectives","volume":"445","author":"Catherman","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nmeth.2074","article-title":"A protease for \u2018middle-down\u2019 proteomics","volume":"9","author":"Wu","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt0303-255","article-title":"Proteomic analysis of post-translational modifications","volume":"21","author":"Mann","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Khoury, G.A., Baliban, R.C., and Floudas, C.A. (2011). Proteome-wide post-translational modification statistics: Frequency analysis and curation of the swiss-prot database. Sci. Rep., 1.","DOI":"10.1038\/srep00090"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibtech.2004.03.007","article-title":"Metabolomics by numbers: Acquiring and understanding global metabolite data","volume":"22","author":"Goodacre","year":"2004","journal-title":"Trends Biotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.foodchem.2015.09.084","article-title":"Studying the effect of storage conditions on the metabolite content of red wine using hilic lc-ms based metabolomics","volume":"197","author":"Arapitsas","year":"2016","journal-title":"Food Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.abb.2015.06.013","article-title":"Metabolomics applied to the pancreatic islet","volume":"589","author":"Gooding","year":"2016","journal-title":"Arch Biochem. Biophys."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s13238-015-0185-x","article-title":"Functional metabolomics: From biomarker discovery to metabolome reprogramming","volume":"6","author":"Peng","year":"2015","journal-title":"Protein Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.abb.2015.08.022","article-title":"Insights into the impact of silver nanoparticles on human keratinocytes metabolism through nmr metabolomics","volume":"589","author":"Carrola","year":"2016","journal-title":"Arch Biochem. Biophys."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1289\/ehp.11338","article-title":"Global DNA hypomethylation is associated with high serum-persistent organic pollutants in greenlandic inuit","volume":"116","author":"Rusiecki","year":"2008","journal-title":"Environ. Health Perspect"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0167-7799(98)01214-1","article-title":"Systematic functional analysis of the yeast genome","volume":"16","author":"Oliver","year":"1998","journal-title":"Trends Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2015.10.004","article-title":"Evaluation and identification of dioxin exposure biomarkers in human urine by high-resolution metabolomics, multivariate analysis and in vitro synthesis","volume":"240","author":"Jeanneret","year":"2016","journal-title":"Toxicol. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jgr.2015.04.006","article-title":"A uplc\/ms-based metabolomics investigation of the protective effect of ginsenosides rg1 and rg2 in mice with alzheimer\u2019s disease","volume":"40","author":"Li","year":"2016","journal-title":"J. Ginseng Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-1258-2_1","article-title":"Overview of mass spectrometry-based metabolomics: Opportunities and challenges","volume":"1198","author":"Gowda","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/wsbm.1198","article-title":"Promise of personalized omics to precision medicine","volume":"5","author":"Chen","year":"2013","journal-title":"Wiley Interdiscip Rev. Syst. Biol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1093\/hmg\/ddn250","article-title":"Genome-based prediction of common diseases: Advances and prospects","volume":"17","author":"Janssens","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature02624","article-title":"Predicting disease using genomics","volume":"429","author":"Bell","year":"2004","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Casamassimi, A., Federico, A., Rienzo, M., Esposito, S., and Ciccodicola, A. (2017). Transcriptome profiling in human diseases: New advances and perspectives. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081652"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm2010001","article-title":"Personalized medicine and cancer","volume":"2","author":"Verma","year":"2012","journal-title":"J. Pers Med."},{"key":"ref_51","first-page":"560","article-title":"Personalized medicine: Part 1: Evolution and development into theranostics","volume":"35","author":"Vogenberg","year":"2010","journal-title":"PT"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.breast.2013.08.007","article-title":"Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?","volume":"22","author":"Chiorean","year":"2013","journal-title":"Breast"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Braicu, C., Selicean, S., Cojocneanu-Petric, R., Lajos, R., Balacescu, O., Taranu, I., Marin, D.E., Motiu, M., Jurj, A., and Achimas-Cadariu, P. (2016). Evaluation of cellular and molecular impact of zearalenone and escherichia coli co-exposure on ipec-1 cells using microarray technology. BMC Genom., 17.","DOI":"10.1186\/s12864-016-2830-z"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.toxlet.2014.10.022","article-title":"Exposure to zearalenone mycotoxin alters in vitro porcine intestinal epithelial cells by differential gene expression","volume":"232","author":"Taranu","year":"2015","journal-title":"Toxicol. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hunter, D.J. (2006). Genomics and proteomics in epidemiology: Treasure trove or \u201chigh-tech stamp collecting\u201d?. Epidemiology, 17.","DOI":"10.1097\/01.ede.0000229955.07579.f0"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-069X-8-54","article-title":"The impact of new research technologies on our understanding of environmental causes of disease: The concept of clinical vulnerability","volume":"8","author":"Vineis","year":"2009","journal-title":"Environ. Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1016\/j.jprot.2012.07.028","article-title":"Mass spectrometry imaging for drug distribution studies","volume":"75","author":"Prideaux","year":"2012","journal-title":"J. Proteom."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Simionescu, D., and Simionescu, A. (2017). Noncoding RNAs in lung cancer angiogenesis. Physiologic and Pathologic Angiogenesis-Signaling Mechanisms and Targeted Therapy, InTech. Chapter 14.","DOI":"10.5772\/64121"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpba.2005.08.038","article-title":"Applications of mass spectrometry in early stages of target based drug discovery","volume":"40","author":"Deng","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mas.20019","article-title":"Biochemical applications of mass spectrometry in pharmaceutical drug discovery","volume":"24","author":"Geoghegan","year":"2005","journal-title":"Mass Spectrom Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejps.2012.03.011","article-title":"Mass spectrometric tools for cell and tissue studies","volume":"46","author":"Ketola","year":"2012","journal-title":"Eur J. Pharm. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.aca.2015.01.008","article-title":"Direct drug analysis from oral fluid using medical swab touch spray mass spectrometry","volume":"861","author":"Pirro","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/14789450.2014.901157","article-title":"Mass spectrometry-based plasma proteomics: State of the art and future outlook","volume":"11","author":"Pernemalm","year":"2014","journal-title":"Expert Rev. Proteom."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-014-9685-5","article-title":"Recommendations for validation of lc-ms\/ms bioanalytical methods for protein biotherapeutics","volume":"17","author":"Jenkins","year":"2015","journal-title":"Aaps J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1073\/pnas.1310524111","article-title":"Chemo-informatic strategy for imaging mass spectrometry-based hyperspectral profiling of lipid signatures in colorectal cancer","volume":"111","author":"Veselkov","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1111\/febs.12502","article-title":"Proteomics methods for subcellular proteome analysis","volume":"280","author":"Drissi","year":"2013","journal-title":"FEBS J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/metabo3020440","article-title":"Small molecule identification with molgen and mass spectrometry","volume":"3","author":"Meringer","year":"2013","journal-title":"Metabolites"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1074\/mcp.M500331-MCP200","article-title":"Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins","volume":"5","author":"Anderson","year":"2006","journal-title":"Mol. Cell Proteom."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jprot.2011.03.019","article-title":"Drug localization in different lung cancer phenotypes by maldi mass spectrometry imaging","volume":"74","author":"Fehniger","year":"2011","journal-title":"J. Proteom."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"650A","DOI":"10.1021\/ac981991q","article-title":"Sample preparation for lc\/ms\/ms: Analyzing biological and environmental samples","volume":"70","author":"Henion","year":"1998","journal-title":"Anal. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jchromb.2018.08.025","article-title":"A rapid and sensitive liquid chromatography\/tandem mass spectrometry assay for simultaneous quantitation of disopyramide and its major metabolite, mono-isopropyl-disopyramide, in rat plasma and its application to a pharmacokinetic study","volume":"1096","author":"Pham","year":"2018","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1055\/s-2007-981458","article-title":"Liquid chromatography tandem-mass spectrometry (lc-ms\/ms)-technique and applications in endocrinology","volume":"115","author":"Vogeser","year":"2007","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3332\/ecancer.2014.418","article-title":"Is it safe for pregnant health-care professionals to handle cytotoxic drugs? A review of the literature and recommendations","volume":"8","author":"Gilani","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/acsmedchemlett.8b00480","article-title":"Tissue imaging by mass spectrometry: A practical guide for the medicinal chemist","volume":"10","author":"Johnson","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/CCO.0b013e3283376e15","article-title":"Advances in the systemic treatment of head and neck cancers","volume":"22","author":"Specenier","year":"2010","journal-title":"Curr. Opin. Oncol."},{"key":"ref_77","first-page":"149","article-title":"Recurrent oral cancer: Current and emerging therapeutic approaches","volume":"3","author":"Hier","year":"2012","journal-title":"Front. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/rcm.662","article-title":"Determination of drug binding sites to proteins by electrospray ionisation mass spectrometry: The interaction of cisplatin with transferrin","volume":"16","author":"Allardyce","year":"2002","journal-title":"Rapid Commun. Mass Spectrom"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-199142050-00005","article-title":"Cyclophosphamide toxicity. Characterising and avoiding the problem","volume":"42","author":"Fraiser","year":"1991","journal-title":"Drugs"},{"key":"ref_80","first-page":"43","article-title":"Methotrexate-induced acute leukemia: Report of three cases and review of the literature","volume":"2","author":"Eltayeb","year":"2009","journal-title":"Clin. Med. Case Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1215\/15228517-2006-037","article-title":"High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary cns lymphoma","volume":"9","author":"Kiewe","year":"2007","journal-title":"Neuro Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IGC.0000000000000647","article-title":"Continuous low-dose oral cyclophosphamide and methotrexate as maintenance therapy in patients with advanced ovarian carcinoma after complete clinical response to platinum and paclitaxel chemotherapy","volume":"26","author":"Motawei","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000490458","article-title":"Tolerability and efficacy of neoadjuvant chemotherapy with a tri-weekly interval methotrexate, doxorubicin, vinblastine, and cisplatin regimen for patients with locally advanced bladder cancer","volume":"11","author":"Arai","year":"2018","journal-title":"Case Rep. Oncol."},{"key":"ref_84","first-page":"6228","article-title":"Progress in the chemotherapeutic treatment of osteosarcoma","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11894-018-0658-1","article-title":"Update on the use of thiopurines and methotrexate in inflammatory bowel disease","volume":"20","author":"Johnson","year":"2018","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0065-2571(94)90025-6","article-title":"The methotrexate story: A paradigm for development of cancer chemotherapeutic agents","volume":"34","author":"Huennekens","year":"1994","journal-title":"Adv. Enzym. Regul."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jchromb.2009.04.025","article-title":"Simultaneous determination of cyclophosphamide and carboxyethylphosphoramide mustard in human plasma using online extraction and electrospray tandem mass spectrometry (htlc-esi-ms\/ms)","volume":"877","author":"Bai","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2013.07.026","article-title":"A validated lc-ms\/ms method for rapid determination of methotrexate in human saliva and its application to an excretion evaluation study","volume":"937","author":"Rodin","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1039\/c4an00094c","article-title":"Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using lc-ms\/ms","volume":"139","author":"Bylda","year":"2014","journal-title":"Analyst"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"374819","DOI":"10.1155\/2015\/374819","article-title":"An optimized high throughput clean-up method using mixed-mode spe plate for the analysis of free arachidonic acid in plasma by lc-ms\/ms","volume":"2015","author":"Wang","year":"2015","journal-title":"Int. J. Anal. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/pmic.200300677","article-title":"Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry","volume":"4","author":"Chertov","year":"2004","journal-title":"Proteomics"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pca.2505","article-title":"Extraction for metabolomics: Access to the metabolome","volume":"25","author":"Mushtaq","year":"2014","journal-title":"Phytochem. Anal."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1038\/bcj.2015.39","article-title":"A novel antibody-drug conjugate targeting sail for the treatment of hematologic malignancies","volume":"5","author":"Kim","year":"2015","journal-title":"Blood Cancer J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1128\/MCB.00678-12","article-title":"Large fk506-binding proteins shape the pharmacology of rapamycin","volume":"33","author":"Marz","year":"2013","journal-title":"Mol. Cell Biol"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Xie, J., Wang, X., and Proud, C.G. (2016). Mtor inhibitors in cancer therapy. F1000Res, 5.","DOI":"10.12688\/f1000research.9207.1"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/TP.0b013e3181a05b7a","article-title":"Management of side effects of sirolimus therapy","volume":"87","author":"Stallone","year":"2009","journal-title":"Transplantation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","article-title":"Strategies for the management of adverse events associated with mtor inhibitors","volume":"28","author":"Kaplan","year":"2014","journal-title":"Transpl. Rev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5500\/wjt.v6.i1.183","article-title":"Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation","volume":"6","author":"Ramirez","year":"2016","journal-title":"World J. Transpl."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1074\/jbc.M305912200","article-title":"Fkbp12-rapamycin-associated protein or mammalian target of rapamycin (frap\/mtor) localization in the endoplasmic reticulum and the golgi apparatus","volume":"279","author":"Drenan","year":"2004","journal-title":"J. Biol Chem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1074\/jbc.M109.066621","article-title":"Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27kip1","volume":"285","author":"Moss","year":"2010","journal-title":"J. Biol Chem."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Ye, L., Lee, J., Xu, L., Mohammed, A.U., Li, W., Hale, J.S., Tan, W.G., Wu, T., Davis, C.W., and Ahmed, R. (2017). Mtor promotes antiviral humoral immunity by differentially regulating cd4 helper t cell and b cell responses. J. Virol, 91.","DOI":"10.1128\/JVI.01653-16"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1515\/CCLM.2002.008","article-title":"Quantification of sirolimus by liquid chromatography-tandem mass spectrometry using on-line solid-phase extraction","volume":"40","author":"Vogeser","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/clinchem\/42.9.1417","article-title":"Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by hplc\/electrospray-mass spectrometry","volume":"42","author":"Streit","year":"1996","journal-title":"Clin. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1373\/clinchem.2006.069252","article-title":"The maldi-tof mass spectrometric view of the plasma proteome and peptidome","volume":"52","author":"Hortin","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jasms.2009.09.016","article-title":"On-tissue protein identification and imaging by maldi-ion mobility mass spectrometry","volume":"21","author":"Stauber","year":"2010","journal-title":"J. Am. Soc. Mass Spectrom"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1373\/clinchem.2005.053090","article-title":"High-resolution serum proteomic profiling of alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures","volume":"51","author":"Lopez","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Pirman, D.A., Efuet, E., Ding, X.P., Pan, Y., Tan, L., Fischer, S.M., DuBois, R.N., and Yang, P. (2013). Changes in cancer cell metabolism revealed by direct sample analysis with maldi mass spectrometry. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061379"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.4155\/bio.11.232","article-title":"Maldi imaging mass spectrometry: Bridging biology and chemistry in drug development","volume":"3","author":"Castellino","year":"2011","journal-title":"Bioanalysis"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3892\/ijo.2014.2788","article-title":"Maldi tof imaging mass spectrometry in clinical pathology: A valuable tool for cancer diagnostics (review)","volume":"46","author":"Kriegsmann","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"59376","DOI":"10.18632\/oncotarget.19587","article-title":"Serum peptidome profiling for the diagnosis of colorectal cancer: Discovery and validation in two independent cohorts","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Kan, F., Ye, L., Yan, T., Cao, J., Zheng, J., and Li, W. (2017). Proteomic and transcriptomic studies of hbv-associated liver fibrosis of an aav-hbv-infected mouse model. BMC Genom., 18.","DOI":"10.1186\/s12864-017-3984-z"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.7150\/jca.17900","article-title":"Discovery of non-invasive glycan biomarkers for detection and surveillance of gastric cancer","volume":"8","author":"Qin","year":"2017","journal-title":"J. Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Swiatly, A., Horala, A., Hajduk, J., Matysiak, J., Nowak-Markwitz, E., and Kokot, Z.J. (2017). Maldi-tof-ms analysis in discovery and identification of serum proteomic patterns of ovarian cancer. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3467-2"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Wang, L., Tang, C., Xu, B., Yang, L., Qu, L., Li, L., Li, X., Wang, W., Qin, H., and Gao, H. (2017). Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179000"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.21873\/cgp.20031","article-title":"Proteomics analysis of tissue samples reveals changes in mitochondrial protein levels in parathyroid hyperplasia over adenoma","volume":"14","author":"Akpinar","year":"2017","journal-title":"Cancer Genom. Proteom."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.1408129111","article-title":"Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis","volume":"111","author":"Calligaris","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","unstructured":"Spengler, B., Hubert, M., and Kaufmann, R. (June, January 29). Maldi ion imaging and biological ion imaging with a new scanning uv-laser microprobe. Proceedings of the 42nd Annual Conference on Mass Spectrometry and Allied Topics, Chicago, IL, USA."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/labinvest.2014.156","article-title":"Maldi imaging mass spectrometry: Current frontiers and perspectives in pathology research and practice","volume":"95","author":"Aichler","year":"2015","journal-title":"Lab. Investig."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2217\/bmm.15.64","article-title":"Drug localizations in tissue by mass spectrometry imaging","volume":"9","author":"Vegvari","year":"2015","journal-title":"Biomark. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40169-016-0090-9","article-title":"Localization of tamoxifen in human breast cancer tumors by maldi mass spectrometry imaging","volume":"5","author":"Vegvari","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"ref_121","first-page":"3","article-title":"Electrospray ionisation mass spectrometry: Principles and clinical applications","volume":"24","author":"Ho","year":"2003","journal-title":"Clin. Biochem. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"125858","DOI":"10.1155\/2013\/125858","article-title":"Serum biomarkers identification by mass spectrometry in high-mortality tumors","volume":"2013","author":"Tessitore","year":"2013","journal-title":"Int. J. Proteom."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/(SICI)1097-0231(199709)11:14<1493::AID-RCM40>3.0.CO;2-1","article-title":"Characterization of oligosaccharide composition and structure by quadrupole ion trap mass spectrometry","volume":"11","author":"Weiskopf","year":"1997","journal-title":"Rapid Commun. Mass Spectrom"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"245821","DOI":"10.1155\/2011\/245821","article-title":"The application of seldi-tof-ms in clinical diagnosis of cancers","volume":"2011","author":"Liu","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12014-015-9102-9","article-title":"Advances in mass spectrometry-based clinical biomarker discovery","volume":"13","author":"Crutchfield","year":"2016","journal-title":"Clin. Proteom."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PPO.0b013e3182383cab","article-title":"Application of proteomics to cancer early detection","volume":"17","author":"Hanash","year":"2011","journal-title":"Cancer J."},{"key":"ref_127","first-page":"321370","article-title":"Proteomics in cancer biomarkers discovery: Challenges and applications","volume":"2015","author":"Sallam","year":"2015","journal-title":"Dis. Mark."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/j.1582-4934.2011.01355.x","article-title":"Autoantibody signatures: Progress and perspectives for early cancer detection","volume":"15","author":"Desmetz","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15403\/jgld.2014.1121.234.smad","article-title":"Timp-1 expression in human colorectal cancer is associated with smad3 gene expression levels: A pilot study","volume":"23","author":"Ionescu","year":"2014","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gutjnl-2015-309372","article-title":"The clinical and biological significance of mir-224 expression in colorectal cancer metastasis","volume":"65","author":"Ling","year":"2016","journal-title":"Gut"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00016357.2014.986754","article-title":"Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics","volume":"73","author":"Irimie","year":"2015","journal-title":"Acta Odontol. Scand"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrc1041","article-title":"The case for early detection","volume":"3","author":"Etzioni","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ncponc1187","article-title":"Strategies for discovering novel cancer biomarkers through utilization of emerging technologies","volume":"5","author":"Kulasingam","year":"2008","journal-title":"Nat. Clin. Pr. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Pop-Bica, C., Pintea, S., Cojocneanu-Petric, R., Del Sal, G., Piazza, S., Wu, Z.H., Alencar, A.J., Lossos, I.S., Berindan-Neagoe, I., and Calin, G.A. (2018). Mir-181 family-specific behavior in different cancers: A meta-analysis view. Cancer Metastasis Rev.","DOI":"10.1007\/s10555-017-9714-9"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Pop-Bica, C., Gulei, D., Cojocneanu-Petric, R., Braicu, C., Petrut, B., and Berindan-Neagoe, I. (2017). Understanding the role of non-coding rnas in bladder cancer: From dark matter to valuable therapeutic targets. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071514"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41419-017-0102-8","article-title":"The silent healer: Mir-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating e-cadherin expression","volume":"9","author":"Gulei","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/prca.201500055","article-title":"Proteomics of endometrial cancer diagnosis, treatment, and prognosis","volume":"10","author":"Mittal","year":"2016","journal-title":"Proteom. Clin. Appl."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.molonc.2016.07.001","article-title":"Plasma protein profiling in a stage defined pancreatic cancer cohort-implications for early diagnosis","volume":"10","author":"Gerdtsson","year":"2016","journal-title":"Mol. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.lungcan.2016.07.018","article-title":"Autoantibodies against tumor-associated antigens in the early detection of lung cancer","volume":"99","author":"Dai","year":"2016","journal-title":"Lung Cancer"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/ijms12010410","article-title":"Exploring the immunoproteome for ovarian cancer biomarker discovery","volume":"12","author":"Martin","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(00)00131-9","article-title":"Delivery of molecular and cellular medicine to solid tumors","volume":"46","author":"Jain","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/prca.200780012","article-title":"Immunoproteomics: From biomarker discovery to diagnostic applications","volume":"2","author":"Tjalsma","year":"2008","journal-title":"Proteom. Clin. Appl."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Willitzki, A., Hiemann, R., Peters, V., Sack, U., Schierack, P., R\u00f6diger, S., Anderer, U., Conrad, K., Bogdanos, D.P., and Reinhold, D. (2012). New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin. Dev. Immunol., 2012.","DOI":"10.1155\/2012\/284740"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/cclm-2012-0191","article-title":"Current state of diagnostic technologies in the autoimmunology laboratory","volume":"51","author":"Tozzoli","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Meeusen, E.N., Lim, E., and Mathivanan, S. (2017). Secreted tumor antigens-immune biomarkers for diagnosis and therapy. Proteomics.","DOI":"10.1002\/pmic.201600442"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/ijc.24504","article-title":"Implementation of a novel microarray-based diagnostic test for cancer of unknown primary","volume":"125","author":"Ma","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1373\/clinchem.2004.038950","article-title":"Evaluation of serum protein profiling by surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility","volume":"51","author":"Semmes","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_148","first-page":"3609","article-title":"Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men","volume":"62","author":"Adam","year":"2002","journal-title":"Cancer Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/clinchem\/48.10.1835","article-title":"Boosted decision tree analysis of surface-enhanced laser desorption\/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients","volume":"48","author":"Qu","year":"2002","journal-title":"Clin. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3892\/ijo.2016.3732","article-title":"Metabolomic profiling of breast tumors using ductal fluid","volume":"49","author":"Marian","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1038\/srep06802","article-title":"The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics","volume":"4","author":"Wang","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"966","DOI":"10.7150\/ijbs.9810","article-title":"Metabolic profiles are principally different between cancers of the liver, pancreas and breast","volume":"10","author":"Budhu","year":"2014","journal-title":"Int. J. Biol Sci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"87496","DOI":"10.18632\/oncotarget.11754","article-title":"A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput gc-ms analysis","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"53102","DOI":"10.18632\/oncotarget.10632","article-title":"Development of a sequential workflow based on lc-prm for the verification of endometrial cancer protein biomarkers in uterine aspirate samples","volume":"7","author":"Lesur","year":"2016","journal-title":"Oncotarget"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.biopha.2017.05.146","article-title":"Mass spectrometry as a tool for biomarkers searching in gynecological oncology","volume":"92","author":"Banach","year":"2017","journal-title":"Biomed. Pharm."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.acr.2016.11.004","article-title":"In situ metabolomics in cancer by mass spectrometry imaging","volume":"134","author":"Buck","year":"2017","journal-title":"Adv. Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fonc.2017.00013","article-title":"A timely shift from shotgun to targeted proteomics and how it can be groundbreaking for cancer research","volume":"7","author":"Faria","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Cawthorn, T.R., Moreno, J.C., Dharsee, M., Tran-Thanh, D., Ackloo, S., Zhu, P.H., Sardana, G., Chen, J., Kupchak, P., and Jacks, L.M. (2012). Proteomic analyses reveal high expression of decorin and endoplasmin (hsp90b1) are associated with breast cancer metastasis and decreased survival. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030992"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jprot.2012.11.004","article-title":"A mass spectrometry-based plasma protein panel targeting the tumor microenvironment in patients with breast cancer","volume":"81","author":"Cohen","year":"2013","journal-title":"J. Proteom."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Broker, M.E., Lalmahomed, Z.S., Roest, H.P., van Huizen, N.A., Dekker, L.J., Calame, W., Verhoef, C., Ijzermans, J.N., and Luider, T.M. (2013). Collagen peptides in urine: A new promising biomarker for the detection of colorectal liver metastases. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070918"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1021\/pr1005197","article-title":"Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry","volume":"9","author":"Chen","year":"2010","journal-title":"J. Proteome. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1021\/pr4005025","article-title":"Hyperplex-mrm: A hybrid multiple reaction monitoring method using mtraq\/itraq labeling for multiplex absolute quantification of human colorectal cancer biomarker","volume":"12","author":"Yin","year":"2013","journal-title":"J. Proteome. Res."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Catenacci, D.V., Liao, W.L., Thyparambil, S., Henderson, L., Xu, P., Zhao, L., Rambo, B., Hart, J., Xiao, S.Y., and Bengali, K. (2014). Absolute quantitation of met using mass spectrometry for clinical application: Assay precision, stability, and correlation with met gene amplification in ffpe tumor tissue. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100586"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"M111","DOI":"10.1074\/mcp.M111.009290","article-title":"Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from n-linked glycoproteins in human plasma","volume":"10","author":"Lee","year":"2011","journal-title":"Mol. Cell Proteom."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1074\/mcp.M112.023325","article-title":"Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (lc-ms-mrm) analysis of site-specific glycoforms of haptoglobin in liver disease","volume":"12","author":"Sanda","year":"2013","journal-title":"Mol. Cell Proteom."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1074\/mcp.M113.031252","article-title":"Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis c-infected patients","volume":"12","author":"Mustafa","year":"2013","journal-title":"Mol. Cell Proteom."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jprot.2009.11.010","article-title":"Proteomic analysis of laser-microdissected paraffin-embedded tissues: (2) mrm assay for stage-related proteins upon non-metastatic lung adenocarcinoma","volume":"73","author":"Nishimura","year":"2010","journal-title":"J. Proteom."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jprot.2014.04.031","article-title":"Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (adlc) plasmas by lectin-capturing and targeted mass spectrometry","volume":"106","author":"Ahn","year":"2014","journal-title":"J. Proteom."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Welinder, C., Jonsson, G.B., Ingvar, C., Lundgren, L., Baldetorp, B., Olsson, H., Breslin, T., Rezeli, M., Jansson, B., and Fehniger, T.E. (2014). Analysis of alpha-synuclein in malignant melanoma-development of a srm quantification assay. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110804"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/pmic.201500224","article-title":"A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva","volume":"16","author":"Kawahara","year":"2016","journal-title":"Proteomics"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/pmic.201300402","article-title":"Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma","volume":"14","author":"Iuga","year":"2014","journal-title":"Proteomics"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.1013699108","article-title":"Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer","volume":"108","author":"Cima","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"454256","DOI":"10.1155\/2015\/454256","article-title":"Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2d-dige and ms","volume":"2015","author":"Geisler","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1074\/mcp.M113.028365","article-title":"Identification of a novel proteoform of prostate specific antigen (snp-l132i) in clinical samples by multiple reaction monitoring","volume":"12","author":"Vegvari","year":"2013","journal-title":"Mol. Cell Proteom."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Martinez-Aguilar, J., Clifton-Bligh, R., and Molloy, M.P. (2015). A multiplexed, targeted mass spectrometry assay of the s100 protein family uncovers the isoform-specific expression in thyroid tumours. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1217-x"},{"key":"ref_176","first-page":"639","article-title":"Prediction of response in cancer immunotherapy","volume":"31","author":"Characiejus","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI26022","article-title":"Differential exoprotease activities confer tumor-specific serum peptidome patterns","volume":"116","author":"Villanueva","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/425905a","article-title":"Clinical proteomics: Written in blood","volume":"425","author":"Liotta","year":"2003","journal-title":"Nature"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Rusch, T., Bayry, J., Werner, J., Shevchenko, I., and Bazhin, A.V. (2017). Immunotherapy as an option for cancer treatment. Arch. Immunol. Exp.","DOI":"10.1007\/s00005-017-0491-5"},{"key":"ref_180","first-page":"1432","article-title":"Breakthrough of the year 2013. Cancer immunotherapy","volume":"342","year":"2013","journal-title":"Science"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"388","DOI":"10.21037\/atm.2017.06.47","article-title":"The combination of checkpoint immunotherapy and targeted therapy in cancer","volume":"5","author":"Karachaliou","year":"2017","journal-title":"Ann. Transl Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fonc.2017.00249","article-title":"Surgical management of stage iiia non-small cell lung cancer","volume":"7","author":"Berzenji","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1021\/acs.analchem.7b03643","article-title":"High-resolution capillary zone electrophoresis with mass spectrometry peptide mapping of therapeutic proteins: Peptide recovery and post-translational modification analysis in monoclonal antibodies and antibody-drug conjugates","volume":"89","author":"Dada","year":"2017","journal-title":"Anal. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ymeth.2015.03.007","article-title":"Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells","volume":"81","author":"Wang","year":"2015","journal-title":"Methods"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jprot.2017.10.014","article-title":"Improvement of ubiquitylation site detection by orbitrap mass spectrometry","volume":"172","author":"Bezstarosti","year":"2018","journal-title":"J. Proteom."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-60761-842-3_13","article-title":"Protein quantitation using mass spectrometry","volume":"673","author":"Zhang","year":"2010","journal-title":"Methods Mol. Biol"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Gundry, R.L., White, M.Y., Murray, C.I., Kane, L.A., Fu, Q., Stanley, B.A., and Van Eyk, J.E. (2010). Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow. Curr. Protoc. Mol. Biol, 90.","DOI":"10.1002\/0471142727.mb1025s88"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1021\/jacs.7b05571","article-title":"Targeted protein detection using an all-in-one mass spectrometry cartridge","volume":"139","author":"Zhang","year":"2017","journal-title":"J. Am. Chem. Soc"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/bmm.13.101","article-title":"Mass spectrometry in cancer biomarker research: A case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens","volume":"8","author":"Prieto","year":"2014","journal-title":"Biomark. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1074\/mcp.RA117.000314","article-title":"Optimization of experimental parameters in data-independent mass spectrometry significantly increases depth and reproducibility of results","volume":"16","author":"Bruderer","year":"2017","journal-title":"Mol. Cell Proteom."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/10\/2576\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:55:07Z","timestamp":1760187307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/10\/2576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,25]]},"references-count":190,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["ijms20102576"],"URL":"https:\/\/doi.org\/10.3390\/ijms20102576","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,25]]}}}